Green synthesis of methoxy-poly(ethylene glycol)-block-poly(l-lactide-co-glycolide) copolymer using zinc proline as a biocompatible initiator for irinotecan delivery to colon cancer in vivo. (18th November 2020)
- Record Type:
- Journal Article
- Title:
- Green synthesis of methoxy-poly(ethylene glycol)-block-poly(l-lactide-co-glycolide) copolymer using zinc proline as a biocompatible initiator for irinotecan delivery to colon cancer in vivo. (18th November 2020)
- Main Title:
- Green synthesis of methoxy-poly(ethylene glycol)-block-poly(l-lactide-co-glycolide) copolymer using zinc proline as a biocompatible initiator for irinotecan delivery to colon cancer in vivo
- Authors:
- Giram, Prabhanjan S.
Wang, Julie Tzu-Wen
Walters, Adam A.
Rade, Priyanka P.
Akhtar, Muhammad
Han, Shunping
Faruqu, Farid N.
Abdel-Bar, Hend M.
Garnaik, Baijayantimala
Al-Jamal, Khuloud T. - Abstract:
- Abstract : Green synthesis of mPEG–PLGA and nanoformulation for delivery of irinotecan to colon cancer. Abstract : Poly(lactic- co -glycolic acid) (PLGA) is the most commonly described biocompatible copolymer used in biomedical applications. In this work, a green synthetic approach based on the biocompatible zinc proline complex, as an initiator for PLGA synthesis, is reported for the first time for the synthesis of methoxy-poly(ethylene glycol)- block -poly(l -lactic- co -glycolic acid) (mPEG–PLGA). mPEG–PLGA with controlled molecular weight and narrow polydispersity was synthesised. Its potential for delivery of irinotecan (Ir), a poorly water-soluble chemotherapeutic drug used for the treatment of colon and pancreatic cancer, was studied. Nanoparticles of controlled size (140–160 nm), surface charge (∼−10 mV), release properties and cytotoxicity against CT-26 (colon) and BxPC-3 (pancreatic) cancer cells, were prepared. Tumor accumulation was confirmed by optical imaging of fluorescently labelled nanoparticles. Unlike Tween® 80 coated NP-Ir, the Pluronic® F-127 coated NP-Ir exhibits significant tumor growth delay compared to untreated and blank formulation treated groups in the CT-26 subcutaneous tumor model, after 4 treatments of 30 mg irinotecan per kg dose. Overall, this proof-of-concept study demonstrates that the newly synthesized copolymer, via a green route, is proven to be nontoxic, requires fewer purification steps and has potential applications in drug delivery.
- Is Part Of:
- Biomaterials science. Volume 9:Number 3(2021)
- Journal:
- Biomaterials science
- Issue:
- Volume 9:Number 3(2021)
- Issue Display:
- Volume 9, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 9
- Issue:
- 3
- Issue Sort Value:
- 2021-0009-0003-0000
- Page Start:
- 795
- Page End:
- 806
- Publication Date:
- 2020-11-18
- Subjects:
- Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://pubs.rsc.org/en/journals/journalissues/bm ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/d0bm01421d ↗
- Languages:
- English
- ISSNs:
- 2047-4830
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.724000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 15846.xml